VNRX News and Press, VolitionRX Limited From 03/19/24

Volition appoints Dr Andrew Retter as Chief Medical Officer PR Newswire HENDERSON, Nev. , March 19, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has appointed Dr Andrew Retter as its Ch...

Volition to Share Nu.Q® NETs Strategy Update at Upcoming Webinar PR Newswire HENDERSON, Nev. , Feb. 2, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE American: VNRX) ("Volition"), a multi-national epigenetics company, is taking part in a webinar hos...

2024-01-18 04:54:59 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips The International Monetary Fund believes that most of the impact from tighter money policies has already affected the U.S. economy, with the rest expected this year. Despite worries about a rec...

Volition Issues Business Review 2023 PR Newswire HENDERSON, Nev. , Jan. 4, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has issued a Business Review of 2023, outlining its key highlights from th...

2024-01-02 15:33:59 ET More on VolitionRX VolitionRx Limited (VNRX) Q3 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on VolitionRX Historical earnings data for VolitionRX Financial information for VolitionRX For further details see...

2023-12-14 13:25:37 ET More on VolitionRX VolitionRx Limited (VNRX) Q3 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on VolitionRX Historical earnings data for VolitionRX Financial information for VolitionRX For further details see...

VolitionRx Secures Approximately $5.5 Million in Belgium Regional Government Financing from Wallonie Entreprendre PR Newswire HENDERSON, Nev. , Dec. 5, 2023 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics c...

2023-11-27 12:33:49 ET More on VolitionRX VolitionRx Limited (VNRX) Q3 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on VolitionRX Historical earnings data for VolitionRX Financial information for VolitionRX For further details see...

2023-11-15 15:41:07 ET VolitionRx Limited (VNRX) Q3 2023 Earnings Conference Call November 15, 2023 8:30 AM ET Company Participants Scott Powell - Executive Vice President, Investor Relations Cameron Reynolds - President and Group Chief Executive Officer Terig Hu...

VolitionRx Limited Announces Third Quarter 2023 Financial Results and Business Update PR Newswire Conference call to discuss financial and operational results scheduled for Wednesday, November 15 , at 8:30 a.m. U.S. Eastern Time HENDERSON, Nev. , ...